Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2023
June 2023, Vol 14, No 3 - Online Only
June 2023, Vol 14, No 3 - Online Only
Research Indicates Fewer People Understand the Link Between HPV and Certain Cancers
By
Phoebe Starr
Cancer Prevention
,
AACR 2023 Annual Meeting
June 2023, Vol 14, No 3 - Online Only
Vaccination against human papillomavirus (HPV) can prevent several types of cancer, including cervical, oral/oropharyngeal, penile, and anal cancers. Unfortunately, vaccination rates, as well as public knowledge regarding the link between HPV and these cancers, are lagging, according to research presented during the 2023 American Association for Cancer Research Annual Meeting.
Read More
Physician Shortages Forcing Medical Group Leaders to Be More Flexible in Their Staffing Models
By
MGMA Staff Members
Healthcare Administration
June 2023, Vol 14, No 3 - Online Only
An April 4, 2023, Medical Group Management Association
Stat
poll found that almost one-half (47%) of medical group leaders have added or created part-time or flexible-schedule physician roles in the past year, while 53% did not.
Read More
Long-Term Financial Toxicity Has Substantial Impact on HRQoL Among Partners of Colorectal Cancer Survivors
Survivorship
,
Financial Toxicity
June 2023, Vol 14, No 3 - Online Only
A new study has found that partners of colorectal cancer survivors experienced long-term financial toxicity that was associated with worse health-related quality of life due to systems- and individual-level behavioral factors.
Read More
National Black Family Cancer Awareness Week
Cancer Awareness
June 2023, Vol 14, No 3 - Online Only
National Black Family Cancer Awareness Week will be held June 15, 2023, through June 21, 2023.
Read More
Investigational mRNA-Based Vaccine May Offer New Hope for Patients With High-Risk Melanoma
By
Phoebe Starr
Emerging Therapies
,
Melanoma
,
Skin Cancer
,
AACR 2023 Annual Meeting
June 2023, Vol 14, No 3 - Online Only
During the 2023 American Association for Cancer Research Annual Meeting, researchers presented results from a phase 2b clinical trial demonstrating significant improvement in recurrence-free survival in patients with high-risk melanoma who were treated with a combination of an investigational personalized mRNA-based vaccine plus the immune checkpoint inhibitor pembrolizumab (Keytruda), compared with pembrolizumab alone.
Read More
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
By
Wayne Kuznar
NCCN
,
Leukemia
,
Lymphoma
,
NCCN 2023 Conference Highlights
,
Hematologic Malignancies
June 2023, Vol 14, No 3 - Online Only
In a session during the 2023 National Comprehensive Cancer Network (NCCN) Annual Conference, Deborah M. Stephens, DO, provided important updates to treatment recommendations for patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and identified key factors for selecting frontline and subsequent therapies, including
IGHV
gene status, 17p deletion/
TP53
mutation status, age, patient comorbidities, and resistance mutations.
Read More
Optimal Systemic Therapy for Renal Cell Carcinoma Is Still Evolving
By
Wayne Kuznar
NCCN
,
NCCN 2023 Conference Highlights
,
Renal-Cell Carcinoma
,
Genitourinary Cancers
June 2023, Vol 14, No 3 - Online Only
Surgery is typically the gold standard for patients with biopsy-proven, clear cell, renal cell carcinoma with no evidence of metastatic disease, said Eric Jonasch, MD, in a session during the 2023 National Comprehensive Cancer Network Conference. In this setting, there is probably not a role for systemic neoadjuvant treatment, as response rates of 15% to 45% have been recorded with axitinib (Inlyta), sunitinib (Sutent), and other tyrosine kinase inhibitors.
Read More
Immunotherapy After Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer
By
Sharon Reynolds
Bladder Cancer
,
Immunotherapy
June 2023, Vol 14, No 3 - Online Only
Updated results from a large clinical trial confirm that, for some patients with bladder cancer that can be removed with surgery, receiving immunotherapy immediately afterwards is an effective treatment.
Read More
Biomarker Testing Helps Tailor Cancer Treatment, Improve Outcomes, Says New CancerCare Survey
Biomarkers
June 2023, Vol 14, No 3 - Online Only
Biomarker testing is a necessary tool in the advancing world of precision cancer treatment. According to a new survey released by Cancer
Care
, a leading national cancer support organization, biomarker testing helped physicians tailor therapy for nearly all the respondent patients (93%) whose cancers were tested over the past 3 years.
Read More
Financial Navigation Can Reduce the Financial Toxicity of Cancer Care
By
Carmen Phillips
Financial Toxicity
June 2023, Vol 14, No 3 - Online Only
Results from a new study add to the evidence that programs aimed at reducing the financial burden of cancer treatment can save money and improve the quality of life of people with cancer and their loved ones.
Read More
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma